Diet, Endothelial Function and Pediatric Hyperlipidemia
饮食、内皮功能和小儿高脂血症
基本信息
- 批准号:7632787
- 负责人:
- 金额:$ 49.82万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-04-01 至 2011-07-31
- 项目状态:已结题
- 来源:
- 关键词:9 year oldAdherenceAdolescenceAdolescentAdultAffectAgeAge-YearsAmerican Heart AssociationAntiatherogenicApolipoprotein EApolipoproteins BArteriesAtherosclerosisBehaviorBehavior TherapyBiological MarkersBloodBlood VesselsCardiovascular systemCause of DeathCell Adhesion MoleculesChildChildhoodCholesterolClassClinicalClinical ResearchClinical TrialsConsumptionControlled Clinical TrialsCoronary ArteriosclerosisCoronary heart diseaseCountryCoupledCrossover DesignDailyDevelopmentDietDietary CholesterolDietary ComponentDietary FiberDietary InterventionDietary SupplementationDiseaseDisease ManagementDocosahexaenoic AcidsDoseDouble-Blind MethodE-SelectinEarly DiagnosisEffectivenessEicosapentaenoic AcidEndothelial CellsEndotheliumExperimental ModelsF2-IsoprostanesFamilial Combined HyperlipidemiaFamilial HypercholesterolemiaFamily history ofFatty AcidsFatty acid glycerol estersFishesFoodFunctional disorderFutureGene MutationGeneral PopulationGenotypeGrantHealthHealth Care CostsHeartHigh Density Lipoprotein CholesterolHigh Density LipoproteinsHyperlipidemiaHypertensionIncidenceIndividualInflammationInflammatoryInflammatory ResponseInheritedInjuryIntercellular adhesion molecule 1Interleukin-1InterventionIntervention StudiesLDL Cholesterol LipoproteinsLeukocytesLipidsLipoprotein (a)Lipoprotein (a-)LipoproteinsLow-Density LipoproteinsMeasurementMeasuresMediatingMediterranean DietMonitorMonounsaturated Fatty AcidsMorbidity - disease rateNitric OxideNutsOleic AcidOleic AcidsOlive oil preparationOmega-3 Fatty AcidsOnline SystemsOperative Surgical ProceduresOutcomeOxidative StressP-SelectinPharmacotherapyPhasePlacebo ControlPlantsPlasmaPlatelet ActivationPrevalencePreventionProcessProductionPropertyProtocols documentationQuality of lifeRandomizedRecommendationResearchResistanceResolutionRiskRoleSecondary PreventionSmooth Muscle MyocytesStructureSupplementationTestingTherapeuticTriglyceridesUltrasonographyUnited StatesVascular Cell Adhesion Molecule-1VasodilationVery low density lipoproteinWeekalpha-Linolenic Acidatherogenesisbasebrachial arterycell motilitycost effectivecytokinedaydesignearly onsetfruits and vegetablesgroup counselinghypercholesterolemiaimprovedinsightintervention programlipid disorderlipoprotein-associated phospholipase A(2)low density lipoprotein inhibitormonocytemortalityoxidationoxidized low density lipoproteinparticlepreventprogramstherapy design
项目摘要
Coronary heart disease (CHD) continues to be the leading cause of death in the United States. Children with
elevated cholesterol levels are especially vulnerable and are at high risk for early onset CHD. Endothelial
dysfunction, the earliest phase of coronary atherosclerosis, is present in children with elevated cholesterol
levels as early as 8 years of age. The long term objective of this study is to develop dietary interventions for
the prevention and treatment of endothelial dysfunction in children with common lipid disorders including
familial hypercholesterolemia (FH) and familial combined hyperlipidemia (FCH). Increasing evidence suggests
that the Mediterranean diet and ?-3 fatty acids found in fish have cardioprotective effects. The specific aims of
the study are to: determine whether a Mediterranean diet alone or combined with ?-3 fatty acids
(eicosapentaenoic acid, docosahexaenoic acid or eicosapentaenoic & docosahexaenoic acids) improve
endothelial function; evaluate the effects of the dietary interventions on lipids and lipoprotein subclasses;
evaluate the effects of the dietary interventions on biomarkers for oxidative stress and inflammation. This
study is a randomized, double-blind, placebo-controlled clinical trial that includes 102 children (ages 8-18)
treated with the Mediterranean diet and ?-3 fatty acid supplements. A dietary educational behavioral
intervention will be conducted over 6 months with individual counseling, group sessions and an interactive
web-based program. Endothelial function will be measured non-invasively by high resolution ultrasound of the
brachial artery at baseline, 6, 12, 18 and 24 weeks. This study is unique because it is a new intervention
designed for children at high risk for early CHD with a dietary component and supplementation with ?-3 fatty
acids. If effective, this intervention would be broadly applicable and lend valuable insight about dietary therapy
to prevent the progression of CHD in hyperlipidemic children.
冠心病(CHD)仍然是美国的主要死亡原因。儿童
胆固醇水平升高尤其容易受到影响,并且是早发冠心病的高风险。内皮
功能障碍是冠状动脉粥样硬化的最早阶段,存在于胆固醇升高的儿童中
早在8岁的水平。本研究的长期目标是制定饮食干预措施,
预防和治疗常见脂质紊乱儿童的内皮功能障碍,包括
家族性高胆固醇血症(FH)和家族性混合型高脂血症(FCH)。越来越多的证据表明
地中海饮食和?在鱼类中发现的3种脂肪酸具有心脏保护作用。的具体目标
这项研究是:确定地中海饮食是单独还是与?3脂肪酸
(二十碳五烯酸、二十二碳六烯酸或二十碳五烯酸和二十二碳六烯酸)改善
内皮功能;评价饮食干预对脂质和脂蛋白亚类的影响;
评估饮食干预对氧化应激和炎症生物标志物的影响。这
研究是一项随机、双盲、安慰剂对照的临床试验,包括102名儿童(8-18岁)
用地中海饮食治疗,3脂肪酸补充剂。饮食教育行为
干预将在6个月内进行,包括个人咨询,小组会议和互动
基于Web的程序。内皮功能将通过高分辨率超声非侵入性地测量,
基线、6、12、18和24周时的肱动脉。这项研究是独一无二的,因为它是一种新的干预措施
专为儿童在高风险的早期冠心病与饮食组成部分和补充?- 3脂肪
acids.如果有效,这种干预将广泛适用,并提供有关饮食疗法的宝贵见解
预防高血脂儿童CHD的进展。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARY B ENGLER其他文献
MARY B ENGLER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARY B ENGLER', 18)}}的其他基金
Phospholipid Transfer Protein Mutations In Dyslipidemias
血脂异常中的磷脂转移蛋白突变
- 批准号:
6620553 - 财政年份:2002
- 资助金额:
$ 49.82万 - 项目类别:
Phospholipid Transfer Protein Mutations In Dyslipidemias
血脂异常中的磷脂转移蛋白突变
- 批准号:
6418755 - 财政年份:2002
- 资助金额:
$ 49.82万 - 项目类别:
Phospholipid Transfer Protein Mutations In Dyslipidemias
血脂异常中的磷脂转移蛋白突变
- 批准号:
6698063 - 财政年份:2002
- 资助金额:
$ 49.82万 - 项目类别:
OMEGA-3 FATTY ACIDS AND CARDIOVASCULAR RISK FACTORS
OMEGA-3 脂肪酸和心血管风险因素
- 批准号:
2256896 - 财政年份:1992
- 资助金额:
$ 49.82万 - 项目类别:
OMEGA-3 FATTY ACIDS AND CARDIOVASCULAR RISK FACTORS
OMEGA-3 脂肪酸和心血管风险因素
- 批准号:
3476456 - 财政年份:1992
- 资助金额:
$ 49.82万 - 项目类别:
OMEGA-3 FATTY ACIDS AND CARDIOVASCULAR RISK FACTORS
OMEGA-3 脂肪酸和心血管风险因素
- 批准号:
3476457 - 财政年份:1992
- 资助金额:
$ 49.82万 - 项目类别:
OMEGA-3 FATTY ACIDS AND CARDIOVASCULAR RISK FACTORS
OMEGA-3 脂肪酸和心血管风险因素
- 批准号:
2256894 - 财政年份:1992
- 资助金额:
$ 49.82万 - 项目类别:
OMEGA-3 FATTY ACIDS AND CARDIOVASCULAR RISK FACTORS
OMEGA-3 脂肪酸和心血管风险因素
- 批准号:
2256895 - 财政年份:1992
- 资助金额:
$ 49.82万 - 项目类别:
相似海外基金
An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
- 批准号:
10057526 - 财政年份:2023
- 资助金额:
$ 49.82万 - 项目类别:
Grant for R&D
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
- 批准号:
490105 - 财政年份:2023
- 资助金额:
$ 49.82万 - 项目类别:
Operating Grants
I-Corps: Medication Adherence System
I-Corps:药物依从性系统
- 批准号:
2325465 - 财政年份:2023
- 资助金额:
$ 49.82万 - 项目类别:
Standard Grant
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
- 批准号:
10821172 - 财政年份:2023
- 资助金额:
$ 49.82万 - 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
- 批准号:
10766947 - 财政年份:2023
- 资助金额:
$ 49.82万 - 项目类别:
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
- 批准号:
10772887 - 财政年份:2023
- 资助金额:
$ 49.82万 - 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
- 批准号:
10594350 - 财政年份:2023
- 资助金额:
$ 49.82万 - 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
- 批准号:
10748465 - 财政年份:2023
- 资助金额:
$ 49.82万 - 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
- 批准号:
10591441 - 财政年份:2023
- 资助金额:
$ 49.82万 - 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
- 批准号:
491109 - 财政年份:2023
- 资助金额:
$ 49.82万 - 项目类别:
Fellowship Programs














{{item.name}}会员




